Literature DB >> 29878933

Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists.

Sean R Williamson1,2, Priya Rao3, Ondrej Hes4, Jonathan I Epstein5, Steven C Smith6, Maria M Picken7, Ming Zhou8, Maria S Tretiakova9, Satish K Tickoo10, Ying-Bei Chen10, Victor E Reuter10, Stewart Fleming11, Fiona M Maclean12, Nilesh S Gupta1, Naoto Kuroda13, Brett Delahunt14, Rohit Mehra15, Christopher G Przybycin16, Liang Cheng17, John N Eble17, David J Grignon17, Holger Moch18, Jose I Lopez19, Lakshmi P Kunju15, Pheroze Tamboli3, John R Srigley20, Mahul B Amin21, Guido Martignoni22, Michelle S Hirsch23, Stephen M Bonsib24, Kiril Trpkov25.   

Abstract

Staging criteria for renal cell carcinoma differ from many other cancers, in that renal tumors are often spherical with subtle, finger-like extensions into veins, renal sinus, or perinephric tissue. We sought to study interobserver agreement in pathologic stage categories for challenging cases. An online survey was circulated to urologic pathologists interested in kidney tumors, yielding 89% response (31/35). Most questions included 1 to 4 images, focusing on: vascular and renal sinus invasion (n=24), perinephric invasion (n=9), and gross pathology/specimen handling (n=17). Responses were collapsed for analysis into positive and negative/equivocal for upstaging. Consensus was regarded as an agreement of 67% (2/3) of participants, which was reached in 20/33 (61%) evaluable scenarios regarding renal sinus, perinephric, or vein invasion, of which 13/33 (39%) had ≥80% consensus. Lack of agreement was especially encountered regarding small tumor protrusions into a possible vascular lumen, close to the tumor leading edge. For gross photographs, most were interpreted as suspicious but requiring histologic confirmation. Most participants (61%) rarely used special stains to evaluate vascular invasion, usually endothelial markers (81%). Most agreed that a spherical mass bulging well beyond the kidney parenchyma into the renal sinus (71%) or perinephric fat (90%) did not necessarily indicate invasion. Interobserver agreement in pathologic staging of renal cancer is relatively good among urologic pathologists interested in kidney tumors, even when selecting cases that test the earliest and borderline thresholds for extrarenal extension. Disagreements remain, however, particularly for tumors with small, finger-like protrusions, closely juxtaposed to the main mass.

Entities:  

Mesh:

Year:  2018        PMID: 29878933     DOI: 10.1097/PAS.0000000000001087

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.

Authors:  Takashi Yoshida; Chisato Ohe; Toyonori Tsuzuki; Motohiko Sugi; Hidefumi Kinoshita; Koji Tsuta; Tadashi Matsuda
Journal:  Int J Clin Oncol       Date:  2019-09-17       Impact factor: 3.402

2.  Towards a More Standardized Approach to Pathologic Reporting of Pancreatoduodenectomy Specimens for Pancreatic Ductal Adenocarcinoma: Cross-continental and Cross-specialty Survey From the Pancreatobiliary Pathology Society Grossing Working Group.

Authors:  Deepti Dhall; Jiaqi Shi; Daniela S Allende; Kee-Taek Jang; Olca Basturk; Volkan Adsay; Grace E Kim
Journal:  Am J Surg Pathol       Date:  2021-10-01       Impact factor: 6.298

3.  Needle tract seeding in renal tumor biopsies: experience from a single institution.

Authors:  Yan Zhou; Paari Murugan; Faqian Li; Lihong Bu
Journal:  Diagn Pathol       Date:  2021-05-16       Impact factor: 2.644

4.  External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88).

Authors:  Zine-Eddine Khene; Alessandro Larcher; Jean-Christophe Bernhard; Nicolas Doumerc; Idir Ouzaid; Umberto Capitanio; François-Xavier Nouhaud; Romain Boissier; Nathalie Rioux-Leclercq; Alexandre De La Taille; Philippe Barthelemy; Francesco Montorsi; Morgan Rouprêt; Pierre Bigot; Karim Bensalah
Journal:  Eur Urol Open Sci       Date:  2021-10-05

Review 5.  Artificial Intelligence and Digital Pathology: Challenges and Opportunities.

Authors:  Hamid Reza Tizhoosh; Liron Pantanowitz
Journal:  J Pathol Inform       Date:  2018-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.